CHF

GPCR up 47% yearly, but ACT Capital exits $2.6M stake. Biotech volatility looms.

Nvidia's 80% surge faces scrutiny as GS resets forecast. AI dominance questioned, but $200+ breakout hints at more upside.

SCHB & SPTM: 33% 1-yr returns, 0.03% fees, tech-heavy. SCHB has more stocks, SPTM longer history.

Intel's stock hits record high on Apple deal news, undercutting TSMC by 25%. Government sees billions.

Aramco's Q1 profit up 26% despite 1B barrels lost. Oil recovery slows, but war drives prices.

XLP boasts 6.4% 1-yr return & 2.6% yield vs PBJ's 6.6% return & 1.5% yield. XLP's low fees win.

Gen-Wealth bets $5.7M on CORO ETF's 31.4% return, eyeing cheaper int'l valuations vs. US tech.